发明名称 PREBIOTIC FORMULATIONS AND METHODS OF USE
摘要 Provided are methods and pharmaceutical compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and pharmaceutical compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to subject in need thereof a pharmaceutical composition comprising a prebiotic, optionally in combination with effective amount of a probiotic microbe or microbes.
申请公布号 US2015087616(A1) 申请公布日期 2015.03.26
申请号 US201214362020 申请日期 2012.11.30
申请人 RITTER PHARMACEUTICALS, INC. 发明人 Ritter Andrew J.;Savaiano Dennis;Barnes David;Klaenhammer Todd
分类号 A61K31/702 主分类号 A61K31/702
代理机构 代理人
主权项 1. A method of preventing, treating, or reducing or eliminating one or more symptoms of a gastrointestinal disorder, the method comprising administering to the subject a pharmaceutical composition comprising: a. an effective amount of a galactooligosaccharides (GOS) composition to prevent, treat, or reduce or eliminate the one or more symptoms of the gastrointestinal disorder; and b. one or more excipients, wherein the gastrointestinal disorder is constipation, diarrhea, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), small intestine bacterial overgrowth (SIBO), hemorrhoids, indigestion or non-ulcer dyspepsia, anal fissures, perianal abscesses, anal fistula, diverticulosis or diverticulitis, colitis, infectious colitis, ulcerative colitis, Crohn's disease, ischemic colitis, radiation colitis, pseudomembranous colitis, C. difficile colitis, ameboma, anismus, peptic ulcers, colic, biliary colic, gastroenteritis, acrodermatitis enteropathica, ileus, intussusception, polyps, obesity, Hirschsprung's disease, diabetes, or metabolic syndrome.
地址 Los Angeles CA US